Jean Zhao, PhD
Investigator, Cancer Biology and Signal Transduction, Dana-Farber
Professor, Harvard Medical School
Targeted Profiling of Translation Rate (TPTR) is an RT-qPCR based method for quantifying RNA translation of specific genes of interest.
Quantifying the expression of a specific gene is a key aspect of many types of biomedical research. Current gene expression analyses predominantly focus on measuring RNA abundance due to their relative ease in isolation, amplification and quantification. While these methods are cost-effective and efficient, they fall short in accurately reflecting the actual protein products of gene expression because RNA translation can be affected by drugs and cellular stresses, such as cancer and nutrient variations.
Measuring the rate of RNA translation offers a more precise correlation with the proteome. Existing translation analysis techniques, such as polysome and ribosome profiling, are labor-intensive, costly, and require specialized equipment. There is a significant need for more accessible, efficient, and cost-effective methods to determine nucleic acid translation rates.
Jean Zhao, PhD, principal investigator in the Department of Cancer Biology at Dana-Farber and her lab, have designed the Targeted Profiling of Translation Rate (TPTR) method to provide a streamlined, targeted approach for quantifying RNA translation of specific genes of interest. TPTR is an RT-qPCR based method which determines the relative abundance of ribosomal occupation rates for specific transcripts of interest as a proxy for the translation rate of the associated genes.
Laboratory results demonstrate that TPTR produces results for specific genes that are comparable to measurements by industry-standard ribosome profiling methods while significantly reducing the time and cost requirements. Unlike traditional methods, TPTR does not require highly specialized instruments or reagents, making it more accessible to a broader range of laboratories.
Benefits:
Team Members: Jean Zhao, PhD, Ben Bicen Li, PhD
Dana-Farber is looking for the right partner interested in licensing these assets for further development as a therapeutic to benefit patients.
Investigator, Cancer Biology and Signal Transduction, Dana-Farber
Professor, Harvard Medical School
Research Fellow, Jean Zhao Lab, Dana-Farber